Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
102,398,919
-
Total 13F shares
-
612,004
-
Share change
-
+311,660
-
Total reported value
-
$441,403
-
Price per share
-
$0.73
-
Number of holders
-
18
-
Value change
-
+$224,539
-
Number of buys
-
12
-
Number of sells
-
5
Institutional Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA) as of Q3 2025
As of 30 Sep 2025,
Pasithea Therapeutics Corp. - Common Stock (KTTA) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
612,004 shares.
The largest 10 holders included
AdvisorShares Investments LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP, XTX Topco Ltd, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, JANE STREET GROUP, LLC, and TWO SIGMA SECURITIES, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.